SOMANTA PHARMACEUTICALS, INC.Somanta Pharmaceuticals Inc. • June 13th, 2006 • Pharmaceutical preparations • Delaware
The purpose of this letter is to memorialize the agreement reached between Somanta Incorporated (the “Company”) and you related to your engagement as an independent consultant to the Company. If you agree to be bound by the terms and conditions set forth in this letter, please countersign this letter below.
SOMANTA LIMITEDSomanta Pharmaceuticals Inc. • June 13th, 2006 • Pharmaceutical preparations
The purpose of this letter is to memorialize the agreement reached between Somanta Limited (the “Company”) and you related to your engagement as an independent consultant to the Company. The parties acknowledge and agree that the Company intends to enter into a Share Exchange Agreement with Bridge Oncology Products, Inc. (“Bridge”) whereby the Company will become a wholly-owned subsidiary of Bridge. At such time, this letter agreement shall be assumed by Bridge and Bridge shall fulfill the Company’s obligations hereunder and references herein to the “Company” shall thereafter be references to Bridge. If you agree to be bound by the terms and conditions set forth in this letter, please countersign this letter below.
DATED 11 October 2004 AND SERVICE AGREEMENT Chief Technology Officer SOMANTIS LTDService Agreement • June 13th, 2006 • Somanta Pharmaceuticals Inc. • Pharmaceutical preparations
